FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952867260> ?p ?o ?g. }

• W2952867260 abstract "Individuals with two copies of the apolipoprotein-1 (APOL1) gene risk variants are at high risk (HR) for non-diabetic kidney disease. The presence of these risk variants is highest in West Africa, specifically in Nigeria. However, there is limited availability of dialysis and kidney transplantation in Nigeria, and most individuals will die soon after developing end-stage renal disease. Blocking the renin angiotensin aldosterone system with angiotensin-converting enzyme inhibitors (ACEi) is a well-recognized strategy to slow renal disease progression in patients with diabetes mellitus with chronic kidney disease (CKD) and in patients with HIV-associated nephropathy. We propose to determine whether presence of the APOL1 HR genotype alters or predicts responsiveness to conventional therapy to treat or prevent CKD and if addition of an ACEi to standard combination antiretroviral therapy (ART) reduces the risk of kidney complications among non-diabetic Nigerian adults.We will screen 2600 HIV-positive adults who have received ART to (1) determine the prevalence of APOL1 risk variants and assess whether APOL1 HR status correlates with prevalent albuminuria, estimated glomerular filtration rate (eGFR), and/or prevalent CKD; (2) assess, via a randomized, placebo-controlled trial (RCT) in a subset of these participants with microalbuminura (n = 280) whether addition of the ACEi, lisinopril, compared to standard of care, significantly reduces the incidence or progression of albuminuria; and (3) determine whether the APOL1 HR genotype is associated with worse kidney outcomes (i.e. eGFR slope or regression of albuminuria) among participants in the RCT.This study will examine the increasing prevalence of kidney diseases in HIV-positive adults in a West African population, and the relationship between these diseases and the APOL1 high-risk genotype. By evaluating the addition of an ACEi to the care of individuals with HIV infection who have albuminuria, our trial will provide definitive evidence to guide strategies for management and clinical care in this population, with the goal of reducing HIV-related kidney complications.ClinicalTrials.gov, NCT03201939 . Registered on 26 August 2016." @default.
• W2952867260 created "2019-06-27" @default.
• W2952867260 creator A5006695781 @default.
• W2952867260 creator A5024733766 @default.
• W2952867260 creator A5025390100 @default.
• W2952867260 creator A5029182112 @default.
• W2952867260 creator A5040681069 @default.
• W2952867260 creator A5041583325 @default.
• W2952867260 creator A5044494633 @default.
• W2952867260 creator A5044924106 @default.
• W2952867260 creator A5046211458 @default.
• W2952867260 creator A5046272962 @default.
• W2952867260 creator A5047760638 @default.
• W2952867260 creator A5048891443 @default.
• W2952867260 creator A5057966400 @default.
• W2952867260 creator A5059689170 @default.
• W2952867260 creator A5062724962 @default.
• W2952867260 creator A5068174835 @default.
• W2952867260 creator A5075115334 @default.
• W2952867260 date "2019-06-10" @default.
• W2952867260 modified "2023-09-26" @default.
• W2952867260 title "Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction “R3” Trial): protocol and study design" @default.
• W2952867260 cites W1623214428 @default.
• W2952867260 cites W1708228311 @default.
• W2952867260 cites W1778525160 @default.
• W2952867260 cites W1968436127 @default.
• W2952867260 cites W1970070985 @default.
• W2952867260 cites W1983973612 @default.
• W2952867260 cites W2002573731 @default.
• W2952867260 cites W2004577335 @default.
• W2952867260 cites W2005096683 @default.
• W2952867260 cites W2011252221 @default.
• W2952867260 cites W2024163727 @default.
• W2952867260 cites W2030823385 @default.
• W2952867260 cites W2032174302 @default.
• W2952867260 cites W2041851511 @default.
• W2952867260 cites W2047162910 @default.
• W2952867260 cites W2048184210 @default.
• W2952867260 cites W2063438134 @default.
• W2952867260 cites W2072124509 @default.
• W2952867260 cites W2073909080 @default.
• W2952867260 cites W2083153199 @default.
• W2952867260 cites W2089613729 @default.
• W2952867260 cites W2092365858 @default.
• W2952867260 cites W2094513337 @default.
• W2952867260 cites W2100586653 @default.
• W2952867260 cites W2102951977 @default.
• W2952867260 cites W2107911711 @default.
• W2952867260 cites W2109444759 @default.
• W2952867260 cites W2114842781 @default.
• W2952867260 cites W2115709314 @default.
• W2952867260 cites W2117871749 @default.
• W2952867260 cites W2118625269 @default.
• W2952867260 cites W2121965895 @default.
• W2952867260 cites W2124641083 @default.
• W2952867260 cites W2126835755 @default.
• W2952867260 cites W2135241380 @default.
• W2952867260 cites W2137096226 @default.
• W2952867260 cites W2149246981 @default.
• W2952867260 cites W2153823387 @default.
• W2952867260 cites W2154655779 @default.
• W2952867260 cites W2156395080 @default.
• W2952867260 cites W2159281103 @default.
• W2952867260 cites W2160180886 @default.
• W2952867260 cites W2162368776 @default.
• W2952867260 cites W2168035113 @default.
• W2952867260 cites W2174221738 @default.
• W2952867260 cites W2236590526 @default.
• W2952867260 cites W2275210128 @default.
• W2952867260 cites W2278877544 @default.
• W2952867260 cites W2320995658 @default.
• W2952867260 cites W2321016119 @default.
• W2952867260 cites W2475261460 @default.
• W2952867260 cites W2554116060 @default.
• W2952867260 cites W2599020891 @default.
• W2952867260 cites W2773911224 @default.
• W2952867260 cites W3000291807 @default.
• W2952867260 cites W4256112366 @default.
• W2952867260 cites W940454206 @default.
• W2952867260 doi "https://doi.org/10.1186/s13063-019-3436-y" @default.
• W2952867260 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6558910" @default.
• W2952867260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31182139" @default.
• W2952867260 hasPublicationYear "2019" @default.
• W2952867260 type Work @default.
• W2952867260 sameAs 2952867260 @default.
• W2952867260 citedByCount "8" @default.
• W2952867260 countsByYear W29528672602020 @default.
• W2952867260 countsByYear W29528672602021 @default.
• W2952867260 countsByYear W29528672602022 @default.
• W2952867260 crossrefType "journal-article" @default.
• W2952867260 hasAuthorship W2952867260A5006695781 @default.
• W2952867260 hasAuthorship W2952867260A5024733766 @default.
• W2952867260 hasAuthorship W2952867260A5025390100 @default.
• W2952867260 hasAuthorship W2952867260A5029182112 @default.
• W2952867260 hasAuthorship W2952867260A5040681069 @default.
• W2952867260 hasAuthorship W2952867260A5041583325 @default.
• W2952867260 hasAuthorship W2952867260A5044494633 @default.
• W2952867260 hasAuthorship W2952867260A5044924106 @default.
• W2952867260 hasAuthorship W2952867260A5046211458 @default.
• W2952867260 hasAuthorship W2952867260A5046272962 @default.

• next